Cannasoul Analytics

Medical Cannabis Analytics

Startup

Cannasoul Analytics is a Caesarea-based startup in the Health Tech & Life Sciences sector, established in 2018. Medical Cannabis Analytics. The company has raised a total of $4M across 2 funding rounds, currently at the Seed stage. Cannasoul Analytics was founded by Prof. David (Dedi) Meiri and Shmuel (Muli) Mandel. Key investors include Synaptogenix, Israel Cannabis Ventures (ICV). The company has 11-50 employees. Core technologies: Biologicals, Herbals.

With $4M in total funding, Cannasoul Analytics is a Seed-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: Released. The company holds 1 patent.

$4M
Raised
2
Rounds
2
Investors
3
Team
2018
Founded
1
Patents
Sector & Technology
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentMedical CannabisBiologicalsHerbals
At a Glance
Investors
Founders
In the News

3 articles covered by sources including www.tipranks.com, www.prnewswire.com, plantsresearchmedicine.com.

www.tipranks.com · Nov 2, 2023
Synaptogenix Acquires Significant Stake in Cannasoul Analtyics Ltd. Co-founded by The Technion - Israel Institute of Technology - TipRanks.com
Read article ↗
Frequently Asked Questions
What does Cannasoul Analytics do?

Cannasoul is an Israeli cannabis drug-discovery company developing therapeutics derived from natural compounds. Cannasoul's proprietary analytical platform, data-driven approach, knowhow, and clinical trial framework support active compound identification and development, from botanical extract through clinical approved formulation. Cannasoul has analyzed over 100 cannabinoids and 100 terpenes. The company's subsidiaries include MyPlant Bio, Psyga Bio, Nidra Logic, and CaVnox.

How much funding has Cannasoul Analytics raised?

Cannasoul Analytics has raised $4M in total funding across 2 rounds. The company is currently at the Seed stage. Key investors include Synaptogenix, Israel Cannabis Ventures (ICV).

Who founded Cannasoul Analytics?

Cannasoul Analytics was founded in 2018 by Prof. David (Dedi) Meiri (Co-founder, CSO & Chairman), Shmuel (Muli) Mandel (Co-founder & CEO).

What sector is Cannasoul Analytics in?

Cannasoul Analytics operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drugs Discovery & Development, Medical Cannabis, with core technologies in Biologicals, Herbals. Target customers: Healthcare & Life Sciences, Healthcare, Laboratories.

Where is Cannasoul Analytics located?

Cannasoul Analytics is based in Tarshish St 5, Caesarea, Israel, Center District.

View Full Profile Classic View Website ↗